MTOR and posterior cortical atrophy: In order to evaluate, whether Torin2-mediated mTOR inhibition can increase the cytotoxic effect of TMZ+AT101/AT101 treatment, PCa was treated with TMZ+AT101/AT101, Torin2, and the combination of Torin2 and TMZ+AT101/AT101 for 3 and 6 days.